Related references
Note: Only part of the references are listed.Risk factors for Covid-19 severity and fatality: a structured literature review
Dominik Wolff et al.
INFECTION (2021)
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R. Barrett et al.
NATURE MEDICINE (2021)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells
Georgina Bowyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
Paul-Henri Lambert et al.
VACCINE (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
Ruklanthi de Alwis et al.
EBIOMEDICINE (2020)
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Caroline Atyeo et al.
IMMUNITY (2020)
Sex differential in COVID-19 mortality varies markedly by age
Sunil S. Bhopal et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng et al.
NATURE IMMUNOLOGY (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
CEPI: Driving Progress Towards Epidemic Preparedness And Response
Dimitrios Gouglas et al.
EPIDEMIOLOGIC REVIEWS (2019)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch et al.
LANCET (2018)
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Quirin Hammer et al.
NATURE IMMUNOLOGY (2018)
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
L. Coughlan et al.
EBIOMEDICINE (2018)
The Critical Role of Biomedical Research in Pandemic Preparedness
Hilary D. Marston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Naif Khalaf Alharbi et al.
VACCINE (2017)
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
Sarah C. Gilbert et al.
VACCINE (2017)
Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans
Alansana Darboe et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis
Patricia A. Jorquera et al.
EXPERT REVIEW OF VACCINES (2016)
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial
Birahim Pierre Ndiaye et al.
LANCET RESPIRATORY MEDICINE (2015)
Combining Viral Vectored and Protein-in-adjuvant Vaccines Against the Blood-stage Malaria Antigen AMA1: Report on a Phase 1a Clinical Trial
Susanne H. Hodgson et al.
MOLECULAR THERAPY (2014)
T cell responses to viral infections - opportunities for peptide vaccination
Sietske Rosendahl Huber et al.
FRONTIERS IN IMMUNOLOGY (2014)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar et al.
NATURE MEDICINE (2013)
Share Paper
